Asymptomatic left circumflex artery stenosis is associated with higher arrhythmia recurrence after persistent atrial fibrillation ablation
Copyright © 2022 Garcia, Clouard, Plank, Degand, Philibert, Laurent, Poupin, Sakhy, Gras, Stühlinger, Szegedi, Herczeg, Simon, Crijns, Marijon, Christiaens and Guenancia..
Background: The pathophysiology of persistent atrial fibrillation (AF) remains unclear. While several studies have demonstrated an association between myocardial infarction and atrial fibrillation, the role of stable coronary artery disease (CAD) is still unknown. As a result, we aimed to assess the association between CAD obstruction and AF recurrence after persistent AF ablation in patients with no history of CAD.
Materials and methods: This observational retrospective study included consecutive patients who underwent routine preprocedural cardiac computed tomography (CCT) before persistent AF ablation between September 2015 and June 2018 in 5 European University Hospitals. Exclusion criteria were CAD or coronary revascularization previously known or during follow-up. Obstructive CAD was defined as luminal stenosis ≥ 50%.
Results: All in all, 496 patients (mean age 61.8 ± 10.0 years, 76.2% males) were included. CHA2DS2-VASc score was 0 or 1 in 225 (36.3%) patients. Obstructive CAD was present in 86 (17.4%) patients. During the follow-up (24 ± 19 months), 207 (41.7%) patients had AF recurrence. The recurrence rate was not different between patients with and without obstructive CAD (43.0% vs. 41.5%, respectively; P = 0.79). When considering the location of the stenosis, the recurrence rate was higher in the case of left circumflex obstruction: 56% vs. 32% at 2 years (log-rank P ≤ 0.01). After Cox multivariate analysis, circumflex artery obstruction (HR 2.32; 95% CI 1.36-3.98; P < 0.01) was independently associated with AF recurrence.
Conclusion: Circumflex artery obstruction detected with CCT was independently associated with 2-fold increase in the risk of AF recurrence after persistent AF ablation. Further research is necessary to evaluate this pathophysiological relationship.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
|---|---|
| Enthalten in: |
Frontiers in cardiovascular medicine - 9(2022) vom: 30., Seite 873135 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Garcia, Rodrigue [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Ablation |
|---|
| Anmerkungen: |
Date Revised 14.10.2022 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3389/fcvm.2022.873135 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM347410723 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM347410723 | ||
| 003 | DE-627 | ||
| 005 | 20231226033743.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fcvm.2022.873135 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1157.xml |
| 035 | |a (DE-627)NLM347410723 | ||
| 035 | |a (NLM)36225960 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Garcia, Rodrigue |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Asymptomatic left circumflex artery stenosis is associated with higher arrhythmia recurrence after persistent atrial fibrillation ablation |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 14.10.2022 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright © 2022 Garcia, Clouard, Plank, Degand, Philibert, Laurent, Poupin, Sakhy, Gras, Stühlinger, Szegedi, Herczeg, Simon, Crijns, Marijon, Christiaens and Guenancia. | ||
| 520 | |a Background: The pathophysiology of persistent atrial fibrillation (AF) remains unclear. While several studies have demonstrated an association between myocardial infarction and atrial fibrillation, the role of stable coronary artery disease (CAD) is still unknown. As a result, we aimed to assess the association between CAD obstruction and AF recurrence after persistent AF ablation in patients with no history of CAD | ||
| 520 | |a Materials and methods: This observational retrospective study included consecutive patients who underwent routine preprocedural cardiac computed tomography (CCT) before persistent AF ablation between September 2015 and June 2018 in 5 European University Hospitals. Exclusion criteria were CAD or coronary revascularization previously known or during follow-up. Obstructive CAD was defined as luminal stenosis ≥ 50% | ||
| 520 | |a Results: All in all, 496 patients (mean age 61.8 ± 10.0 years, 76.2% males) were included. CHA2DS2-VASc score was 0 or 1 in 225 (36.3%) patients. Obstructive CAD was present in 86 (17.4%) patients. During the follow-up (24 ± 19 months), 207 (41.7%) patients had AF recurrence. The recurrence rate was not different between patients with and without obstructive CAD (43.0% vs. 41.5%, respectively; P = 0.79). When considering the location of the stenosis, the recurrence rate was higher in the case of left circumflex obstruction: 56% vs. 32% at 2 years (log-rank P ≤ 0.01). After Cox multivariate analysis, circumflex artery obstruction (HR 2.32; 95% CI 1.36-3.98; P < 0.01) was independently associated with AF recurrence | ||
| 520 | |a Conclusion: Circumflex artery obstruction detected with CCT was independently associated with 2-fold increase in the risk of AF recurrence after persistent AF ablation. Further research is necessary to evaluate this pathophysiological relationship | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a ablation | |
| 650 | 4 | |a atrial fibrillation | |
| 650 | 4 | |a cardiac computed tomography (CCT) | |
| 650 | 4 | |a coronary artery disease | |
| 650 | 4 | |a electrophysiology | |
| 650 | 4 | |a pathophysiology | |
| 650 | 4 | |a pulmonary vein isolation (PVI) | |
| 700 | 1 | |a Clouard, Mathilde |e verfasserin |4 aut | |
| 700 | 1 | |a Plank, Fabian |e verfasserin |4 aut | |
| 700 | 1 | |a Degand, Bruno |e verfasserin |4 aut | |
| 700 | 1 | |a Philibert, Séverine |e verfasserin |4 aut | |
| 700 | 1 | |a Laurent, Gabriel |e verfasserin |4 aut | |
| 700 | 1 | |a Poupin, Pierre |e verfasserin |4 aut | |
| 700 | 1 | |a Sakhy, Saliman |e verfasserin |4 aut | |
| 700 | 1 | |a Gras, Matthieu |e verfasserin |4 aut | |
| 700 | 1 | |a Stühlinger, Markus |e verfasserin |4 aut | |
| 700 | 1 | |a Szegedi, Nándor |e verfasserin |4 aut | |
| 700 | 1 | |a Herczeg, Szilvia |e verfasserin |4 aut | |
| 700 | 1 | |a Simon, Judit |e verfasserin |4 aut | |
| 700 | 1 | |a Crijns, Harry J G M |e verfasserin |4 aut | |
| 700 | 1 | |a Marijon, Eloi |e verfasserin |4 aut | |
| 700 | 1 | |a Christiaens, Luc |e verfasserin |4 aut | |
| 700 | 1 | |a Guenancia, Charles |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Frontiers in cardiovascular medicine |d 2014 |g 9(2022) vom: 30., Seite 873135 |w (DE-627)NLM255534736 |x 2297-055X |7 nnns |
| 773 | 1 | 8 | |g volume:9 |g year:2022 |g day:30 |g pages:873135 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3389/fcvm.2022.873135 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 9 |j 2022 |b 30 |h 873135 | ||